{
    "clinical_study": {
        "@rank": "18141", 
        "arm_group": [
            {
                "arm_group_label": "medical nutrition therapy + metformin", 
                "arm_group_type": "Experimental", 
                "description": "medical nutrition therapy plus trans-gestational metformin (850mg 2 times day)"
            }, 
            {
                "arm_group_label": "medical nutrition therapy", 
                "arm_group_type": "Active Comparator", 
                "description": "medical nutrition therapy without trans-gestational metformin"
            }
        ], 
        "brief_summary": {
            "textblock": "Gestational diabetes mellitus is one of the most frequent complications of pregnancy, that\n      affect between 1 to 14% of population around the world.\n\n      There is a few studies to prevent gestational diabetes mellitus in high risk women as\n      Mexican population.\n\n      Metformin has been used during pregnancy in women with gestational diabetes and women with\n      polycystic ovary syndrome, with acceptable security for mother and fetus.\n\n      Metformin decrease the insulin resistance and weight gain, we believe that metformin may be\n      decrease the risk of gestational diabetes mellitus in high risk women."
        }, 
        "brief_title": "Medical Nutrition Therapy Plus Transgestational Metformin For Preventing Gestational Diabetes In High Risk Mexican Women", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Pregestational Obesity (BMI > 27kg/m2)", 
            "History of Polycystic Ovary Syndrome"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Obesity", 
                "Polycystic Ovary Syndrome", 
                "Diabetes, Gestational"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Mexican women with pregnancy < 16 weeks of gestation, normal oral glucose tolerance\n             75g-2h test and 3 or more criteria:\n\n               1. Body mass index > 27 kg/m2\n\n               2. Maternal age >25\n\n               3. History of infertility with polycystic ovary syndrome\n\n               4. History of macrosomic newborn (Weight >4000g)\n\n               5. History of diabetes mellitus in first or second degree.\n\n               6. History of gestational diabetes in previous pregnancy\n\n        Exclusion Criteria:\n\n          -  Any form of pregestational diabetes\n\n          -  Fasting glucose > 126 mg/dL at first prenatal visit.\n\n          -  seric creatinine > 1.5 mg/dL\n\n          -  Hyperthyroidism\n\n          -  Heart disease\n\n          -  Hepatic disease\n\n          -  Renal diseases\n\n          -  Epilepsy\n\n          -  Lupus\n\n          -  Chronic hypertension."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 27, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01675310", 
            "org_study_id": "Conacyt 151819", 
            "secondary_id": "INPer (Mexico)"
        }, 
        "intervention": [
            {
                "arm_group_label": "medical nutrition therapy + metformin", 
                "intervention_name": "medical nutrition therapy + metformin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "medical nutrition therapy", 
                "description": "medical nutrition therapy", 
                "intervention_name": "Medical nutrition therapy", 
                "intervention_type": "Behavioral"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Metformin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "obesity, polycystic ovary syndrome, gestational diabetes", 
        "lastchanged_date": "August 28, 2012", 
        "location": {
            "contact": {
                "email": "dr.enriquereyes@gmail.com", 
                "last_name": "Enrique Reyes-Mu\u00f1oz, MD", 
                "phone": "52 (55)55209900", 
                "phone_ext": "299"
            }, 
            "contact_backup": {
                "email": "ortegagonzalez@hotmail.com", 
                "last_name": "Carlos Orega-Gonzalez, MD", 
                "phone": "52 (55) 55209900", 
                "phone_ext": "307"
            }, 
            "facility": {
                "address": {
                    "city": "Mexico", 
                    "country": "Mexico", 
                    "zip": "11000"
                }, 
                "name": "National Institute of Perinatology"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Mexico"
        }, 
        "number_of_arms": "2", 
        "official_title": "EFFECTIVITY OF MEDICAL NUTRITION THERAPY PLUS TRANSGESTATIONAL METFORMIN FOR PREVENTING THE INCIDENCE OF GESTATIONAL DIABETES MELLITUS IN HIGH RISK MEXICAN WOMEN.", 
        "overall_contact": {
            "email": "dr.enriquereyes@gmail.com", 
            "last_name": "Enrique Reyes-Mu\u00f1oz, MD", 
            "phone": "52 (55) 55209900", 
            "phone_ext": "299"
        }, 
        "overall_contact_backup": {
            "email": "ortegagonzalez@hotmail.com", 
            "last_name": "Carlos Ortega-Gonzalez, MD", 
            "phone": "52 (55) 55209900", 
            "phone_ext": "307"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Mexico: Institutional Review Board National Institute of Perinatology", 
                "Mexico: National Council of Science and Technology (CONACYT)", 
                "Mexico: COFEPRIS Federal Comission for Prevention of Sanitary Risk"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "oral glucose tolerance test", 
            "measure": "Gestational diabetes mellitus", 
            "safety_issue": "No", 
            "time_frame": "27-28 weeks of gestation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01675310"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes", 
            "investigator_full_name": "ENRIQUE REYES-Munoz MD", 
            "investigator_title": "Clinical Reseach", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "measure of insulin resistance by HOMA-IR, sample of umbilical cord", 
            "measure": "insulin resistance", 
            "safety_issue": "No", 
            "time_frame": "At birth"
        }, 
        "source": "Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes", 
        "sponsors": {
            "collaborator": {
                "agency": "National Council of Science and Technology, Mexico", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "August 2012"
    }
}